Inventor · disambiguated record
Sushant Omprakash Dube
Also filed as: DUBE SUSHANT · DUBE SUSHANT OMPRAKASH
16 granted patents·15 pending applications·33 citations·filing 2011–2025
90Inventor score
Technology areasA61K
Files withSLAYBACK PHARMA LLC23ANI PHARMACEUTICALS INC4AZURITY PHARMACEUTICALS INC2LAD VISHAL1VAYA NAVIN1
Top patents by PatentIndex Score
31 records- 0196US11679105B1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Jun 20, 2023·11 cites·13 claims
- 0296US11590122B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 28, 2023·14 cites·12 claims
- 0394US12357627B2Pharmaceutical compositions of cabozantinibAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Jul 15, 2025·2 cites·18 claims
- 0493US12138255B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·2 cites·6 claims
- 0593US11484518B1Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Nov 1, 2022·2 cites·17 claims
- 0690US12213972B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Granted Feb 4, 2025·2 cites·18 claims
- 0784US12350245B2Stable oral suspensions of baclofenANI PHARMACEUTICALS INC·Filed 2023·Granted Jul 8, 2025·0 cites·19 claims
- 0882US11857524B2Stable oral suspensions of baclofenANI PHARMACEUTICALS INC·Filed 2023·Granted Jan 2, 2024·0 cites·19 claims
- 0982US11696906B2Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Jul 11, 2023·0 cites·8 claims
- 1082US2025302819A1Pharmaceutical compositions of cabozantinibAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1180US11564898B1Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 31, 2023·0 cites·10 claims
- 1278US12343330B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2023·Granted Jul 1, 2025·0 cites·27 claims
- 1378US11957685B2Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2023·Granted Apr 16, 2024·0 cites·24 claims
- 1477US2025221978A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 1577US2024131018A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 1676US12491178B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Granted Dec 9, 2025·0 cites·18 claims
- 1776US2024207278A1Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 1874US2025082617A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 1972US2022387418A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 2071US12194028B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2023·Granted Jan 14, 2025·0 cites·16 claims
- 2171US2025235431A1Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 2270US2025248987A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 2368US11766438B2Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2021·Granted Sep 26, 2023·0 cites·10 claims
- 2464US2024173282A1Stable oral baclofen compositionsANI PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2560US2024050416A1Stable Pharmaceutical Compositions of ApixabanSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 2659US2024189229A1Liquid pharmaceutical compositions of baclofen for oral administrationANI PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2759US2022362235A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 2859US2022280500A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 2943US2011189271A1Pharmaceutical formulations of acid-labile drugsLAD VISHAL·Filed 2011·Application pending·0 cites
- 3042US10952981B2Liquid pharmaceutical compositions of baclofen for oral administrationSLAYBACK PHARMA LLC·Filed 2020·Granted Mar 23, 2021·0 cites·14 claims
- 3141US2012058194A1Pharmaceutical formulations comprising substituted benzimidazole derivativesVAYA NAVIN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sushant Omprakash Dube files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →